Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06330883
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2023-05-23
Brief Title:
Determining the Prevalence of Frailty and Evaluating Its Relationship With Mortality
Sponsor:
Selcuk University
Organization:
Selcuk University
Study Overview
Official Title:
Determining the Prevalence of Frailty in COVID-19 Patients Admitted to the Intensive Care Unit and Evaluating Its Relationship With Mortality
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Covid-19 patients admitted to the intensive care unit of Selcuk University Hospital were included in the study Clinical frailty score was given during admission to the intensive care unit Demographic data laboratory data radiological imaging and vital signs of the patients were recorded Treatment and patient positions were recorded during the intensive care follow-up of the patients Mortality status of the patients 6 months after admission to the ICU was recorded
Detailed Description:
It is planned to include non-pregnant and non-traumatic patients over the age of 18 diagnosed with COVID-19 who are treated in the Intensive Care Unit of Selcuk University Hospital The frailty status will be evaluated by using the clinical frailty scale at the admission of the patients to the intensive care unit Evaluation from the patient himself if the consciousness of the patients is clear If not it will be done near the patient Patients will be divided into two groups using the clinical frailty scale CFS as frail if the score is 5 and non-fragile if the score is 5 Demographic information and vaccination status how many dose and type will be questioned SOFA score APACHE II score will be recorded Routine examinations made from the patient file thorax computed tomography CT imaging laboratory values respiratory support information drug treatments applied patient positions will be recorded Thoracic CT scans severity scores for each of the five lung lobes 0 for no involvement 0 1 for minimal involvement 1-25 2 for mild involvement 26-50 3 for moderate involvement 51 -75 and 4 advanced involvement 76-100 The total severity score will be the sum of the scores of the five lobes If the score is 10 it will be considered as mild involvement and if the score is 10 it will be considered as severe involvement Laboratory values platelet and lymphocyte count albumin sodium ferritin D-dimer crp procalcitonin interleukin-6 and glomerular filtration rate values neutrophillymphocyte ratio plateletlymphocyte ratio CRPAlbumin ratio arterial blood gas will be recorded Whether or not he received respiratory support type invasivenon-invasive positive pressure respiratory support or high-flow nasal oxygen therapy duration will be recorded The use and duration of vasoactive drugs administered renal replacement therapy and its durations will be recorded Patient positions will be recorded as supine lateral decubitus and prone The length of stay in the intensive care unit and mortality of the patients will be recorded Comparisons will be made between frail and non-fragile groups on all these evaluated parameters
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None